management expects the contractual arrangements underlying these
revenues will be renewed and that our investors will use this
adjustment as a basis for measuring our ongoing performance, although
there can be no assurance that such contractual arrangements will be
3) We exclude amortization of intangible assets from this measure because
we believe intangible asset amortization charges do not represent what
our management and our investors believe are the costs of developing,
producing, supporting and selling our products and the costs to support
our internal operating structure.
4) We exclude restructuring and severance costs from this measure because
they tend to occur as a result of specific events such as acquisitions,
divestitures, repositioning our business or other unusual events that
could make comparisons of long-range trends difficult for management or
investors and could distort performance measures involving our internal
investments and the costs to support our operating structure.
CALIPER LIFE SCIENCES, INC.
SELECTED FINANCIAL INFORMATION
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, December 31,
Cash, cash equivalents and marketable
securities $8,897 $18,955
Accounts receivable, net 27,260 30,248
Inventories 21,391 19,572
Other current assets
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved